Swipe om te navigeren naar een ander artikel
Sleep problems in children with autism spectrum disorders (ASD) are under-recognized and under-treated. Identifying treatment value accounting for health effects on family members (spillovers) could improve the perceived cost-effectiveness of interventions to improve child sleep habits. A prospective cohort study (N = 224) was conducted with registry and postal survey data completed by the primary caregiver. We calculated quality of life outcomes for the child and the primary caregiver associated with treatments to improve sleep in the child based on prior clinical trials. Predicted treatment effects for melatonin and behavioral interventions were similar in magnitude for the child and for the caregiver. Accounting for caregiver spillover effects associated with treatments for the child with ASD increases treatment benefits and improves cost-effectiveness profiles.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev). Washington, DC: American Psychiatric Association.
Arnold, L. E., Vitiello, B., McDougle, C., Scahill, L., Shah, B., Gonzalez, N. M., et al. (2003). Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1443–1450. CrossRefPubMed
Bayley, N. (2006). Bayley scales of infant and toddler development–third edition. San Antonio, TX: Harcourt Assessment.
Brouwer, W., van Exel, N., & Tilford, J. (2009). Incorporating caregiver and family effects in economic evaluations of child health. In W. J. Ungar (Ed.), Economic evaluation in child health (pp. 55–76). New York: Oxford University Press. CrossRef
Bureau of Labor Statistics, U. S. D. o. L. (2014). American time use survey— 2013 results (Rep. No. USDL-14-1137). http://www.bls.gov/news.release/pdf/atus.pdf
Cortesi, F., Giannotti, F., Sebastiani, T., Panunzi, S., & Valente, D. (2012). Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: A randomized placebo-controlled trial. Journal of Sleep Research, 21, 700–709. CrossRefPubMed
Glasgow, R. E., & Steiner, J. F. (2012). Comparative effectiveness research to accelerate translation: Recommendations for an emerging field of science. In R. C. Brownson, G. A. Colditz, & E. K. Proctor (Eds.), Dissemination and implementation research in health (pp. 72–92). New York, NY: Oxford University Press.
Gold, M., Siegel, J., Russell, L., & Weinstein, M. (1996). Cost effectiveness in health and medicine. New York, NY: Oxford University Press.
Goldman, S. E., McGrew, S., Johnson, K. P., Richdale, A. L., Clemons, T., & Malow, B. A. (2011). Sleep is associated with problem behaviors in children and adolescents with autism spectrum disorders. Research in Autism Spectrum Disorders, 5, 1223–1229. CrossRef
Kaplan, R., & Anderson, J. (1996). The general health policy model: An integrated approach. In B. Spiker (Ed.), Quality of life and pharmacoeconomics in clinical trials (2nd ed., pp. 309–322). Philadelphia, PA: Lippincott-Raven Publishers.
Kelly, A., Haddix, A., Scanlon, K., Helmick, C., & Mulinare, J. (1996). Cost-effectiveness of strategies to prevent neural tube defects. In J. E. Siegel, L. B. Russell, M. C. Weinstein, & M. R. Gold (Eds.), Cost-effectiveness in health and medicine (pp. 312–349). New York, Oxford: Oxford University Press.
Krakowiak, P., Goodlin-Jones, B., Hertz-Picciotto, I., Croen, L. A., & Hansen, R. L. (2008). Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: A population-based study. Journal of Sleep Researh, 17, 197–206. CrossRef
Levy, S. E., Giarelli, E., Lee, L. C., Schieve, L. A., Kirby, R. S., Cunniff, C., et al. (2010). Autism spectrum disorder and co-occurring developmental, psychiatric, and medical conditions among children in multiple populations of the United States. Journal of Developmental and Behavioral Pediatrics, 31, 267–275. CrossRefPubMed
Lichstein, K. L., Stone, K. C., Donaldson, J., Nau, S. D., Soeffing, J. P., Murray, D., et al. (2006). Actigraphy validation with insomnia. Sleep, 29, 232–239. PubMed
Meltzer, D., & Smith, P. (2012). Theoretical issues relevant to the economic evaluation of health technologies. In M. V. Pauly, T. G. McGuire, & P. P. Barros (Eds.), Handbook of health economics (Vol. 2, pp. 433–470). Oxford, UK: North Holland.
Mullen, E. (1997). Mullen Scales of early learning. Los Angeles, CA: Western Psychological Services.
Owens, J. A., Spirito, A., & McGuinn, M. (2000). The Children’s Sleep Habits Questionnaire (CSHQ): Psychometric properties of a survey instrument for school-aged children. Sleep, 23, 1043–1051. PubMed
Payakachat, N., Tilford, J. M., Kovacs, E., & Kuhlthau, K. (2012). Autism spectrum disorders: A review of measures for clinical, health services and cost-effectiveness applications. Expert Review of Pharmacoeconomics & Outcomes Research, 12, 485–503. CrossRef
Pregibon, D. (1980). Goodness of link tests for generalilzed linear models. Applied Statistics, 29, 15–24. CrossRef
Prosser, L. A., Lamarand, K., Gebremariam, A., & Wittenberg, E. (2015). Measuring family HRQoL spillover effects using direct health utility assessment. Medical Decision Making, 35, 81–93.
Radloff, L. S. (1977). The CES-D Scale: A self-report Depression Scale for research in the general population. Applied Psychological Measurement, 1, 385–401. CrossRef
Ramsey, J. (1969). Tests for specification error in classical linear least squares regression analysis. Journal of the Royal Statisical Society Series B, 31, 350–371.
Reynolds, A. M., & Malow, B. A. (2011). Sleep and autism spectrum disorders. Pediatric Clinic of North America, 58, 685–698. CrossRef
Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of American Academy of Child Adolescent Psychiatry, 47, 921–929. CrossRef
The National Institute for Health and Care Excellence. (2013). Guide to the methods of technology appraisal 2013 London. England: The National Institute for Health and Care Excellence.
Tilford, J. M. & Payakachat, N. (2014). Progress in measuring family spillover effects for economic evaluations. Expert Review of Pharmacoeconomics & Outcomes Research, 16, 1–4.
Ungar, W., & Gerber, A. (2010). The uniqueness of child health and challenges to measuring costs and consequences. In W. Ungar (Ed.), Economic evaluation in child health. New York: Oxford University Press.
- Treatment for Sleep Problems in Children with Autism and Caregiver Spillover Effects
J. Mick Tilford
Karen A. Kuhlthau
Jeffrey M. Pyne
D. Keith Williams
Werner B. F. Brouwer
Richard E. Frye
- Springer US